Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Boehringer Ingelheim Recalls Single Lot of Pradaxa 75 mg Capsules
Boehringer Ingelheim is recalling bottles of Pradaxa 75 mg capsules from lot number 201900 because there is a defect in the packaging that could allow moisture to get into the bottle, reducing the effectiveness of the drug. Pradaxa is approved to reduce the risk of stroke and systemic embolism in patients with atrial fibrillation, a type of irregular heartbeat. For more information, please visit:
Learn More

Generic Lipitor Recall: Ranbaxy Pharmaceuticals Recalls Tablets of Atorvastatin Due to Glass Particles
Ranbaxy Pharmaceuticals Inc. is recalling over 40 lot numbers of its Atorvastatin Calcium Tablets in 10 mg, 20 mg, and 40 mg dosage strengths, packaged in 90 count and 500 count bottles. The recall is being conducted at the pharmacy level because these select batches may contain small glass particles approximately less than 1 millimeter (mm) in size. Ranbaxy is proactively recalling these lots of atorvastatin out of caution, keeping the safety of patients in mind. This recall is being conducted with the full knowledge of the U.S. FDA. Atorvastatin is a cholesterol-lowering medicine and is also available under the brand name Lipitor and through other generic manufacturers. The recall does not affect or relate to the 80mg strength of atorvastatin from Ranbaxy or any other atorvastatin or Lipitor products from other manufacturers. For a list of lot numbers involved in the recall, please visit: For more information, please visit: and,0,2306475.story
Learn More

Date Published Title Drug Source
2012-11-15 Boehringer Ingelheim Recalls Single Lot of Pradaxa 75 mg Capsules Dabigatran Manufacturer
2012-11-26 Generic Lipitor Recall: Ranbaxy Pharmaceuticals Recalls Tablets of Atorvastatin Due to Glass Particles Atorvastatin Manufacturer
2012-11-27 Akorn, Inc. Recalls Two Lots of Tobramycin Ophthalmic Ointment 0.3% Tobramycin FDA
2012-11-27 Stat Rx USA, LLC Recalls a Single Lot of Venlafaxine ER 150mg Tablets Venlafaxine FDA
2012-12-02 Church & Dwight Col, Inc. Recalls Single Lot of Orajel Kids My Way! Anticavity Fluoride Toothpaste Sodium Fluoride FDA
2012-12-02 Dr. Reddy's Laboratories Limited Recalls Single Lot of Quetiapine Tablets, 25mg Quetiapine FDA
2012-12-02 Ranbaxy Pharmaceuticals Inc. Recalls Single Lot of Atorvastatin Tablets, 10 mg Atorvastatin FDA
2012-12-02 Aurobindo Pharma Recalls Single Lot of Northstar Zolpidem Tablets 10 mg Zolpidem FDA
2012-12-02 Medical Pharmaceuticals Corp Recalls Several Lots of in the AcneFree Line of Products Benzoyl Peroxide FDA
2012-12-02 Target Corp. Recalls Several Lots of UP & UP brand, Kid’s Foaming Hand Sanitizer FDA
2012-12-02 Bristol-Myers Squibb Recalls Several Lots of Kombiglyze XR Tablets, Doctor Samples Saxagliptin and Metformin FDA
2012-12-02 Mylan Pharmaceuticals Recalls Single Lot of Doxazosin Tablets 2 mg Doxazosin FDA
2012-12-02 Qualitest Pharmaceuticals Recalls Single Lot of Perphenazine Tablets, 8 mg Perphenazine FDA
2012-12-02 Watson Laboratories Recalls Several Lots of Birth Control Pills: Zovia, Lutera, Zenchent, and Necon Zovia FDA
2012-12-03 Raritan Pharmaceuticals Recalls Several Lots of Store Branded Fiber Supplements Psyllium Husk FDA
2012-12-07 Qualitest Recalls Over One Hundred Lots of Hydrocodone Bitartrate and Acetaminophen Tablets Hydrocodone with Acetaminophen FDA
2012-12-11 GlaxoSmithKline Recalls Several Lots of Advair HFA 45/21 Inhalers Fluticasone Propionate with Salmeterol FDA
2012-12-11 Proctor and Gamble Recalls Select Lots of Vicks NyQuil Cold & Flu, Nighttime Relief FDA
2012-12-12 FDA Publishes Results of Safety Review Update of Chantix and Risk of Heart Attack and Stroke Varenicline FDA
2012-12-17 FDA Warns Against Use of Xyrem With Alcohol, Insomnia Medicines, and Others Sodium Oxybate FDA